×
About 5,330 results

ALLMedicine™ C-peptide Center

Research & Reviews  1,887 results

Preserved C-peptide in survivors of COVID-19: post-hoc analysis.
https://doi.org/10.1111/dom.14608
Diabetes, Obesity & Metabolism; Clarke SA, Phylactou M et. al.

Dec 2nd, 2021 - Preserved C-peptide in survivors of COVID-19: post-hoc analysis.|2021|Clarke SA,Phylactou M,Patel B,Mills EG,Muzi B,|

C-peptide, glycemic control and diabetic complications in T2DM: a real-world study.
https://doi.org/10.1002/dmrr.3514
Diabetes/metabolism Research and Reviews; Huang Y, Wang Y et. al.

Nov 30th, 2021 - 1. To explore the relationship between C-peptide and glycemic control rate and diabetic complications(microvascular complication and cerebral infarction), and provide evidence for stratified treatment of type 2 diabetes based C-peptide. 2. This is...

Maternal Carbohydrate Intake During Pregnancy is Associated with Child Peripubertal Mar...
https://doi.org/10.1017/S1368980021004614
Public Health Nutrition; Mulcahy MC, Tellez-Rojo MM et. al.

Nov 25th, 2021 - Examine the associations of trimester-specific maternal prenatal carbohydrate (CHO) intake with offspring adiposity and metabolic health during the peripuberty. Prospective cohort study in which maternal dietary intake was collected via validated ...

Prevalence and phenotypic features of diabetes due to recessive, non-syndromic WFS1 mut...
https://doi.org/10.1530/EJE-21-0097
European Journal of Endocrinology; Zhu M, Li Y et. al.

Nov 19th, 2021 - Recessive WFS1 mutations are known to cause Wolfram syndrome, a very rare systemic disorder. However, they were also found in non-syndromic diabetes in Han Chinese misdiagnosed with type 1 diabetes, a molecular cause that appears to be considerabl...

see more →

Clinicaltrials.gov  140 results

Diabetes Islet Preservation Immune Treatment
https://clinicaltrials.gov/ct2/show/NCT02586831

Nov 16th, 2021 - To assess whether there is a difference in endogenous insulin secretion, measured as stimulated C-peptide secretion (area under the curve during a 4-hour mixed meal tolerance test), at the 1 year visit, for study subjects receiving combinational t...

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
https://clinicaltrials.gov/ct2/show/NCT05119179

Nov 15th, 2021 - This clinical trial will uncover new mechanisms of inter-individual responses to endogenous and exogenous glucagon-like peptide-1 (GLP-1) in Hispanics/Latinos (H/Ls) with prediabetes. The results move the management of prediabetes, type 2 diabetes...

Regimen Switch After Intensive Insulin Therapy
https://clinicaltrials.gov/ct2/show/NCT04833413

Nov 4th, 2021 - Selecting initial insulin intensive therapy during the period of hospitalization in patients with type 2 diabetes, collect the basic information and biochemical information collection, including gender, age, duration of diabetes, intensive glucose...

A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
https://clinicaltrials.gov/ct2/show/NCT04899271

Oct 25th, 2021 - The study is a phase 2, multicenter, double-blind, placebo-controlled study. It will randomize approximately 75 adult patients with new-onset type 1 diabetes (T1D) and preserved beta-cell function (fasting C-peptide >0.205 nmol/l) at baseline. Pat...

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT05092399

Oct 25th, 2021 - There are NO research interventions, this study is observing a patient's response to clinical interventions. The below describes the investigators methods of observation. Screening: Participants who are listed for surgery by the Bariatric surgical...

see more →

News  105 results

Expanding Obesity Coverage; Tymlos for Male Osteoporosis; T1D Stem Cell Tx Success
https://www.medpagetoday.com/endocrinology/generalendocrinology/95211

Oct 24th, 2021 - If pushed through, the Treat and Reduce Obesity Act would expand access to obesity treatment, using Medicare Part D to cover anti-obesity medication and behavioral therapy. (The Hill) One way to potentially help thwart excess weight in infants: a ...

Cancer Drug May Slow Course of Type 1 Diabetes
https://www.medscape.com/viewarticle/954931

Jul 19th, 2021 - NEW YORK (Reuters Health) - The tyrosine-kinase inhibitor imatinib used to treat chronic myeloid leukemia and other cancers may help preserve beta-cell function in people with recently diagnosed type-1 diabetes, according to findings from a phase-...

Gastrectomy for Gastric Cancer Associated With Weight Loss, Diabetes Remission
https://www.medscape.com/viewarticle/950423

May 4th, 2021 - (Reuters Health) - Gastric cancer patients with diabetes who undergo conventional gastrectomy have an increased likelihood of diabetes remission with greater postoperative weight loss, independent of baseline weight, a recent study suggests. Resea...

Integrating primary care into a community mental health center
https://www.mdedge.com/familymedicine/article/238401/practice-management/integrating-primary-care-community-mental-health
MDedge Family Medicine; Christina Antenucci, MD, Steven Schreiber, RN et. al.

Apr 8th, 2021 - THE CASE John C* is a 57-year-old man with hypertension, hyperlipidemia, and schizophrenia who followed up with a psychiatrist monthly at the community mental health center (CMHC). He had no primary care doctor.

Diabetes Prevention Moves Towards Reality as Studies Published  
https://www.medscape.com/viewarticle/947607

Mar 17th, 2021 - Two newly published studies highlight recent success toward delaying the onset of type 1 diabetes in people at high risk and slowing progression in those with recent onset of the condition. Both studies were initially presented in June 2020 at the...

see more →